[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-veloxis-pharmaceuticals":3,"geo-veloxis-pharmaceuticals":-1,"alternatives-veloxis-pharmaceuticals":24},{"id":4,"slug":5,"name":6,"wikidata_qid":7,"gleif_lei":8,"isin":9,"ultimate_parent_id":9,"hq_country_code":10,"hq_city":11,"founded_year":12,"official_website":13,"manufacturing_countries":9,"logo_url":9,"description":14,"is_eu_headquartered":15,"is_eu_manufactured":16,"eu_score_label":17,"attributes":18,"data_quality":19,"enriched_at":20,"created_at":21,"updated_at":22,"ownership_type":9,"stock_exchange":9,"tax_domicile":9,"ultimate_parent_name":9,"ultimate_parent_country":9,"data_hosting_country":9,"cloud_act_exposure":9,"ai_training_on_user_data":9,"dsa_designation":9,"gdpr_fines_total_eur":9,"gdpr_compliance_status":9,"supply_chain_transparency":9,"sustainable_materials":9,"carbon_neutral":9,"repair_recycling_program":9,"pays_eu_taxes":9,"eu_regulatory_fines":9,"b_corp_certified":9,"ethical_certifications":9,"ownership_disclosed":9,"annual_report_published":9,"supply_chain_audit_published":9,"timeline_events":9,"extended_enriched_at":9,"category_primary_id":9,"category_secondary_id":9,"category_confidence":23},"e2b42454-f1f7-4442-a9ff-106715b630dc","veloxis-pharmaceuticals","Veloxis Pharmaceuticals","Q7919317","5493003DUEOIW0NPT736",null,"DK","Amerika Plads",1999,"https:\u002F\u002Fwww.veloxis.com\u002F","Veloxis Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic products for transplant patients. The company was acquired in 2020 by Asahi Kasei, a Japanese multinational conglomerate, though it maintains operations in Denmark and the United States.",true,false,"eu_hq",{},"complete","2026-07-19T18:36:13.462+00:00","2026-07-09T06:25:10.24652+00:00","2026-07-22T17:18:34.403585+00:00",0,[]]